| Validity of self-reported drug use information among pregnant women M Garg, L Garrison, L Leeman, A Hamidovic, M Borrego, WF Rayburn, ... Maternal and child health journal 20, 41-47, 2016 | 129 | 2016 |
| The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots LN Bakhireva, RD Savich, DW Raisch, S Cano, RD Annett, L Leeman, ... Alcoholism: Clinical and Experimental Research 37 (6), 1008-1015, 2013 | 61 | 2013 |
| The economic burden of sickle cell disease in the United States J Huo, H Xiao, M Garg, C Shah, DJ Wilkie, A Mainous Iii Value in Health 21, S108, 2018 | 39 | 2018 |
| Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace E Dietrich, R Desai, M Garg, H Park, SM Smith The Journal of Clinical Hypertension 22 (1), 6-15, 2020 | 10 | 2020 |
| Diffuse large B-cell lymphoma (DLBCL): a structured literature review of the epidemiology, treatment guidelines, and real-world treatment patterns M Garg, J Takyar, A Dhawan, G Saggu, N Agrawal, A Hall, M Raut, ... Blood 140 (Supplement 1), 12106-12107, 2022 | 7 | 2022 |
| Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study M Garg, V Venugopalan, SM Vouri, V Diaby, NM Iovine, H Park Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (9 …, 2023 | 3 | 2023 |
| Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States GK Dawwas, CE Leonard, M Garg, SM Vouri, SM Smith, JH Flory, ... Diabetes, Obesity and Metabolism 22 (4), 705-710, 2020 | 3 | 2020 |
| Real-World Survival, Healthcare Resource Utilization, and Costs Among US Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed … M Garg, J Puckett, S Kamal-Bahl, M Raut, KE Ryland, JA Doshi, ... Clinical Lymphoma Myeloma and Leukemia 24 (5), e181-e190, 2024 | 2 | 2024 |
| PIN30 Impact of disease severity on healthcare costs in patients with chronic hepatitis C virus infection (HCV) M Garg, H Park Value in Health 22, S199, 2019 | 2 | 2019 |
| Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma M Garg, J Puckett, S Kamal-Bahl, M Raut, KE Ryland, JA Doshi, ... Future Oncology 20 (6), 317-328, 2024 | 1 | 2024 |
| Economic burden and treatment patterns among patients with mantle cell lymphoma in the US: a retrospective claims analysis M Garg, A Satija, Y Song, E Sarpong, B Meade, E Lemus-Wirtz, K Gaburo, ... Blood 140 (Supplement 1), 7920-7921, 2022 | 1 | 2022 |
| ADVANCED GESTATIONAL AGE INCREASES SERUM CARBOHYDRATE DEFICIENT TRANSFERRIN LEVELS IN ABSTINENT PREGNANT WOMEN S Cano, L Robles, WF Rayburn, RD Savich, M Garg, RF Anton, E Leonard, ... Alcoholism-Clinical and Experimental Research 36, 44A-44A, 2012 | 1 | 2012 |
| Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy HM Sineshaw, CM Zettler, J Prescott, M Garg, S Chakraborty, ... Cancer Medicine 13 (7), e7173, 2024 | | 2024 |
| P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG US ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED … M Garg, J Puckett, S Kamal-Bahl, M Raut, K Ryland, S Chakraborty, ... HemaSphere 7 (S3), e7912542, 2023 | | 2023 |
| P1158: REAL-WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND TREATMENT OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) BY LINE OF THERAPY (LOT) H Sineshaw, C Zettler, J Prescott, M Garg, S Chakraborty, E Sarpong, ... HemaSphere 7 (S3), e7626551, 2023 | | 2023 |
| Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL) M Garg, SF Huntington, J Puckett, S Kamal-Bahl, M Raut, KE Ryland, ... Blood 140 (Supplement 1), 10814-10815, 2022 | | 2022 |
| Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data M Garg, A Satija, Y Song, E Sarpong, B Meade, E Lemus-Wirtz, K Gaburo, ... Blood 140 (Supplement 1), 5075-5076, 2022 | | 2022 |
| Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections V Venugopalan, R Crawford, K Ho, M Garg, H Park, S Premraj, K Klinker, ... Journal of Pharmacy Practice 35 (5), 675-679, 2022 | | 2022 |
| Comparison and contrast of antibiotic utilization and outcomes in hospital-acquired pneumonia (HAP), ventilated HAP (vHAP) and ventilator associated pneumonia (VAP) in the … M Garg, X Liu, W Black, K Desai, E Bortnichak, P Moise, L Puzniak PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 179-179, 2021 | | 2021 |
| Trends in inappropriate outpatient antibiotic use in the United States M Garg, H Park PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 535-535, 2019 | | 2019 |
Matthew E BorregoUniversity of New Mexico College of Pharmacy在 salud.unm.edu 的电子邮件经过验证
Matthew E BorregoUniversity of New Mexico College of Pharmacy在 salud.unm.edu 的电子邮件经过验证